Dexmedetomidine NEW
| Price | $39 | $64 | $97 |
| Package | 25mg | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Dexmedetomidine | CAS No.: 113775-47-6 |
| Purity: 99.96% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Dexmedetomidine |
| Description | Dexmedetomidine is a Central alpha-2 Adrenergic Agonist. The mechanism of action of dexmedetomidine is as an Adrenergic alpha2-Agonist. The physiologic effect of dexmedetomidine is by means of General Anesthesia. |
| In vitro | Dexmedetomidine has a relatively high ratio of α2/α1-activity (1620:1 as compared with 220:1 for clonidine) and, therefore, is considered a full agonist of the α2 receptor. This may result in more potent effects of sedation without unwanted cardiovascular effects from α1 receptor activation. The 2-h half-life of dexmedetomidine is nearly 4-fold shorter than that of clonidine, which increases the likelihood that a continuous infusion of dexmedetomidine might be useful for sedation. Dexmedetomidine also has minimum alveolar anesthetic concentration (MAC)-sparing properties, but its use as an anesthetic adjuvant has been complicated by persistent hypotension that has mandated IV fluid administration and vasopressor administration. In addition, its use in large doses is complicated by hypertension from α2 receptor-mediated vascular constriction. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 40 mg/mL (199.72 mM), Sonication is recommended. |
| Keywords | analgesia | Inhibitor | (S)-Medetomidine | adrenoceptor | inhibit | (+)-Medetomidine | Beta Receptor | sedation | Adrenergic Receptor | anxiolysis | Dexmedetomidine |
| Inhibitors Related | Octopamine hydrochloride | Trazodone hydrochloride | Mianserin hydrochloride |
| Related Compound Libraries | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.00/1g |
VIP4Y
|
Dorne Chemical Technology co. LTD
|
2024-09-18 | |
| $50.00/1kg |
VIP5Y
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-09-14 | |
| $50.00/1kg |
Anhui Ruihan Technology Co., Ltd
|
2023-08-16 | ||
| $0.00/100g |
Anhui Zhongda Biotechnology Co., Ltd
|
2023-08-14 | ||
| $0.00/25KG |
Shandong Huisheng Import & Export Co., Ltd.
|
2023-08-10 | ||
| $90.00/1kg |
Anhui Zhongda Biotechnology Co., Ltd
|
2023-08-07 | ||
| $88.00/1KG |
Xiamen Wonderful Bio Technology Co., Ltd.
|
2023-07-24 | ||
| $10.00/1kg |
Shanghai Quedan biology science and technology co., ltd
|
2023-02-23 | ||
| $100.00/5kg |
Hubei Langyou International Trading Co., Ltd
|
2022-06-10 | ||
| $320.00/1kg |
Hebei Mingeng Biotechnology Co., Ltd
|
2022-05-06 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY